Cannabis dispensaries logged 679 events in the first half of 2026, more than in all of 2025. Capri King of Kings House of ...
An experimental drug combining nabilone and gabapentin reduced the severity and bothersomeness of cannabis withdrawal ...
Temple balls, pressed dry sift, little cosmetic jars of sand. David Downs reports from the third annual SF Hash Week on the ...
Illness kept changing the rules of Scott Spolverino’s life. His obsession with flavor led from tea to whisky and, eventually, cannabis.
Grown Rogue’s cultivation story began in Southern Oregon. Today, its flower is grown indoors in Paulsboro, New Jersey, as the company builds its presence in the state.
New Jersey’s Good Times uses cannabinoid ratios, fast-acting gummies, and sharp flavor design to make legal weed easier to ...
Ecuador’s hemp sector is projected to approach or surpass $20 million in 2026 as companies move beyond raw biomass into ...
Thailand is moving closer to putting its medical-only cannabis model into national law, with a new bill that would require licenses across the supply chain, ...
The Netherlands’ regulated cannabis experiment is already reshaping coffeeshop shelves, expanding product variety and driving down flower prices. But early findings show little change in consumption, ...
The grower, author and longtime High Times columnist sat down for episode 200 of the Good PizzZa podcast and walked through ...
This Company Wants to Sell the ‘World’s First’ CBD Pain Tablet. Its Own Trial Didn’t Beat a Placebo.
An Australian company has filed for approval of a THC-free CBD tablet it calls a world first for chronic pain. Its chief executive told 7News the trial didn't outperform placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results